Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie

At Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie, clinical research in neoplasms and hematologic diseases focuses mainly on acute lymphoblastic leukemia and immune-related blood disorders. These studies are designed to improve treatment effectiveness, reduce treatment-related toxicity, and support better disease control in children.

• Children with acute lymphoblastic leukemia
• Hemic and lymphatic diseases and neoplasms
• Testing new treatment approaches and improving safety

Research in this area includes efforts to strengthen leukemia care while also exploring better options for chronic idiopathic thrombocytopenic purpura and congenital thrombotic thrombocytopenic purpura.

The site has an active program in nervous system diseases, with a strong focus on developmental and epileptic encephalopathies. These trials aim to assess long-term safety and tolerability of new therapies while supporting symptom control in children with difficult-to-treat epilepsy syndromes.

• Dravet syndrome
• Lennox-Gastaut syndrome
• CDKL5 deficiency disorder and related rare epilepsies

This research helps evaluate whether newer treatment options can offer safer, more durable seizure management for pediatric patients.

Clinical trials in respiratory tract diseases are centered on childhood interstitial lung disease and other fibrosing lung conditions. The main purpose is to monitor safety and tolerability of treatments intended to slow disease progression and support long-term lung health.

• Childhood interstitial lung disease
• Fibrosing interstitial lung disease
• Evaluating long-term treatment safety

These studies are especially important in pediatric care, where preserving lung function can have a major impact on growth and daily life.

Work in digestive system diseases includes studies in Crohn's disease, with attention to inflammation in the upper gastrointestinal tract. The research is aimed at improving symptom control and finding more effective local treatment options for children.

• Crohn's disease
• Inflammatory lesions of the esophagus, stomach, and duodenum
• Testing treatment effectiveness for intestinal inflammation

These trials add to the pediatric gastroenterology expertise available at the site and help refine care for complex inflammatory bowel disease.

Several studies address immune system diseases, especially conditions where the body’s immune response must be carefully regulated. The research explores new therapies for chronic immune thrombocytopenia, congenital thrombotic thrombocytopenic purpura, and other immune-mediated disorders.

• Chronic idiopathic thrombocytopenic purpura
• Congenital thrombotic thrombocytopenic purpura
• Improving immune control and treatment safety

At this Warsaw pediatric center, these trials focus on whether newer immune-targeted therapies can better support children with serious blood-related autoimmune conditions.

Research in nutritional and metabolic diseases includes studies for children at risk of type 1 diabetes and those with hyperkalaemia. The goal is to improve early intervention, restore normal metabolic balance, and support safer long-term disease management.

• Presymptomatic diabetes type 1
• Hyperkalaemia
• Testing approaches to prevent progression and stabilize metabolism

These trials reflect a broader interest in early detection and practical treatment strategies for pediatric metabolic disorders.

The site also conducts research in nervous system and immune-related conditions such as relapsing multiple sclerosis. These studies are designed to evaluate how well new therapies can control disease activity and maintain long-term safety in children and adolescents.

• Relapsing multiple sclerosis
• Neuroinflammatory disease
• Assessing effectiveness and ongoing safety of treatment

This line of research supports better management of chronic neurologic disease in a pediatric setting.